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Abstract
Background: Recent studies have suggested that walking interventions may be effective (at least in the short
term) at increasing physical activity amongst those people who are the most inactive. This is a leading objective
of contemporary public health policy in the UK and worldwide. However, before committing money from limited
budgets to implement walking interventions more widely in the community, policymakers will want to know
whether similar impacts can be expected and whether any changes will be required to the process to ensure
uptake and success. This paper utilises the findings from a recent community-based pedometer study (Walking for
Wellbeing in the West - WWW) undertaken in Glasgow, Scotland to address issues of feasibility.
Methods: An economic analysis of the WWW study assessed the costs of the interventions (minimal and maximal)
and combined these with the effects to present incremental cost-effectiveness ratios (cost/person achieving the
target of an additional 15,000 steps/week). A qualitative evaluation, involving focus group discussions with WWW
participants and short interviews with members of the WWW research team, explored perceived benefits and
barriers associated with walking, as well as the successful aspects and challenges associated with the interventions.
Results: The incremental cost effectiveness associated with the interventions was estimated as £92 and £591 per
person achieving the target for the minimal and maximal interventions respectively. The qualitative evaluation gave
insight into the process by which the results were achieved, and identified several barriers and facilitators that
would need to be addressed before implementing the interventions in the wider community, in order to ensure
their effective transfer. These included assessing the impact of the relationship between researchers and
participants on the results, and the motivational importance of monitoring and assessing performance.
Conclusions: The results suggest that pedometer based walking interventions may be considered cost-effective
and suitable for implementation within the wider community. However, several research gaps remain, including
the importance and impact of the researcher/participant relationship, the impact of assessment on motivation and
effectiveness, and the longer term impact on physical and mental health, resource utilisation and quality of life.
Trial registration: Current Control Trials Ltd ISRCTN88907382
Background
Promoting physical activity, particularly among the most
inactive, is a leading aim of contemporary public health
policy in the UK [1,2]. Walking has been identified as
the mode of physical activity most likely to appeal to
inactive people [2,3]. A recent systematic review of
interventions to promote walking concluded that inter-
ventions targeted at the individual, such as brief advice,
telecommunications and supported use of pedometers
“could contribute substantially towards increasing the
activity levels of the most sedentary” [4]. There is a
growing body of evidence to suggest that pedometers,
combined with a goal-setting programme, can be an
effective short term motivational tool to increase walk-
ing by between 2,000 and 2,500 steps/day [5,6]. How-
ever, the systematic review of walking interventions [4]
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any medium, provided the original work is properly cited.also noted that most existing research provides evidence
of short term efficacy (less than 12 weeks) rather than
longer term effectiveness, and there remain few commu-
nity-based studies of pedometer interventions that pro-
vide long-term follow-up greater than 12 months [5]. In
addition, studies are often based on small, convenience
or volunteer samples and so provide little evidence
about what happens once the programme has been
adopted and implemented more widely [4].
Policymakers seeking to spend money from limited
budgets to improve physical a c t i v i t ya m o n g s tt h em o s t
inactive, will be curious to know whether they can
expect walking interventions to be effective should they
be adopted more widely in the community. In addition,
they will be keen to ascertain the most appropriate form
of these interventions to implement and whether there
are any changes to the intervention and/or implementa-
tion process that could impact positively on the uptake
and success of the intervention once it is promoted
more widely in the community.
The aim of this paper is to utilise information gener-
ated from a recent community-based pedometer study
(Walking for Wellbeing in the West - WWW) underta-
ken in Glasgow, Scotland. The study involved four core
elements (behavioural, psychological, health and envir-
onmental evaluations) and two supplementary studies
(economic and qualitative evaluations). This paper
focuses on the findings of the supplementary studies, to
address these issues of concern to the policymaker and
to identify any gaps in the evidence base. In this way,
the paper corresponds to recent Medical Research
Council (MRC) guidance for evaluating complex inter-
ventions which suggests the importance of evaluating
both outcomes and process in order to address “ak e y
question in evaluating complex interventions [of]...
whether they are effective in everyday practice” [7].
In what follows, we introduce the community-based
study and detail the methods employed for the supple-
mentary economic and qualitative evaluations. The
paper summarises the results of these studies and dis-
cusses the potential impact of these results for policy-
makers considering the widespread introduction of a
pedometer based walking programme.
Community-based pedometer study
Walking for Wellbeing in the West (WWW) found that
an individualised, pedometer based intervention was
effective in initiating (at 12 weeks) and maintaining (at
12 months) walking behaviour change in Scottish men
and women who were not achieving the recommenda-
tions for physical activity at baseline [8-10]. The study
involved seventy-nine participants (women = 63, age =
49.2 ± 8.9 years) randomly assigned between two walk-
ing interventions - maximal (n = 39, women = 31) and
minimal (n = 40, women = 32). For an initial period of
12 weeks, the minimal intervention group constituted a
waiting list control and were requested to maintain nor-
mal levels of walking.
The maximal intervention involved the participants
receiving an individualised walking programme over
12 weeks, a pedometer (Omron HJ-109e) and an indivi-
dual physical activity consultation (average 30 minutes)
with a trained member of the research team. The con-
sultation was based upon the transtheoretical model of
exercise behaviour change [11] and was structured to
enhance motivation and help participants develop strate-
gies to increase their walking( f o re x a m p l e ,p r o d u c i n g
walking plans and goals) and to overcome barriers (for
example, identifying social support). At the end of the
12 week intervention, participants receiving the maximal
intervention had a follow-up, individual physical activity
consultation (average 30 minutes), also based on the
transtheoretical model [11]. This second consultation
focused on strategies to avoid relapse and maintain
activity levels. Further material provided to the maximal
intervention group included a physical activity advice
leaflet (at 24 weeks) and a follow-up consultation (aver-
age eight minutes) via the telephone (at 36 weeks). The
aim of this additional support was to remind partici-
pants of the benefits of maintaining their walking
behaviour.
After 12 weeks, the waiting list control group received
the minimal intervention. This involved participants
receiving an identical, individualised walking programme
(also over 12 weeks) and a pedometer, but no 30 minute
individual physical activity consultation. Instead, the
minimal intervention involved brief advice concerning
goal setting and self monitoring (average five minutes)
at the start of the intervention. At the end of their
12 week structured programme (week 24) and 12 weeks
later (week 36) the minimal intervention group each
received a short (average five minutes) individual feed-
back session relating to their current levels of walking
and use of the pedometer (rather than the 30 minute
follow-up physical activity consultation received by the
maximal intervention group). Participants in the mini-
mal intervention group did not receive any of the addi-
tional material described above. For further details on
the study rationale and design see Fitzsimons et al.
(2008) [10].
Analysis of post intervention data (12 weeks) for the
maximal intervention group showed increased walking
and improved mood (Positive and Negative Affect Sche-
dule), both statistically significant compared with base-
line and the waiting list control group [8]. Follow-up at
12 months for both maximal and minimal intervention
groups suggests that improvements over baseline values
in walking and positive affect were achieved and
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counts from levels achieved immediately post interven-
tion. There was no statistically significant difference
between groups [9].
Methods
Economic evaluation
Economic evaluation compares the additional cost asso-
ciated with a new programme/policy (for example, the
introduction of a pedometer based walking intervention)
with the additional outcomes achieved as a result of the
change (for example the change in weekly step count),
compared to the alternative programme(s) available. The
aim is to inform resource allocation decisions by asses-
s i n gt h ev a l u ef o rm o n e yo ft h ep r o g r a m m e / p o l i c y
change and determining whether the change is a good
use of scarce resources compared to the alternative ways
of using those resources.
The economic analysis of WWW sought to assess the
costs and outcomes, measured over 12 months, asso-
ciated with the maximal and minimal interventions, as
well as with “usual behaviour” as represented by the
waiting list control. The aim of the analysis was to
determine whether a pedometer based walking interven-
tion could be considered cost-effective and, if so, in
which format (minimal or maximal).
The costing was restricted to the resources associated
with providing the intervention. Table 1 details the
resource use and unit costs associated with the maximal
and minimal interventions. The assumption was made
that there are no costs associated with the “usual beha-
viour” group. Unit cost values were taken from pub-
lished estimates [12] or estimated from the costs
incurred by the trial centre.
The measure of outcome employed in the economic
analysis for both the maximal and minimal interventions
is the number of participants achieving and maintaining
a target of an additional 15,000 steps/week from pre-
intervention levels (i.e. baseline for maximal intervention
and week 12 for minimal intervention). This target
equates to the public health guidance of achieving
150 minutes of moderate-intensity activity over the
course of a week [13], under the assumption that mod-
erate intensity walking is achieved by a step rate of
approximately 100 steps/min [14,15]. The effect of
“usual behaviour” is determined from the waiting list
control as the number of participants achieving a target
of an additional 15,000 steps/week between baseline and
week 12 under the assumption that if these participants
had continued to receive no intervention they would
maintain that level of walking.
Cost-effectiveness results are typically presented as
incremental cost-effectiveness ratios (ICERs) which
identify the additional costs associated with an interven-
tion per additional unit of outcome generated by the
intervention, compared to standard treatment (see equa-
tion 1 below).
ICER = incremental cost/incremental outcome (1)
For WWW, the ICER is presented in terms of the
additional costs associated with the provision of the
intervention per additional person achieving the target
o faw e e k l yi n c r e a s eo f≥ 15,000 steps. As the chosen
measure of outcome is specific to walking interventions,
it does not enable comparison of cost-effectiveness to
interventions in other areas (for example, screening or
smoking cessation). In order to allow such comparisons
an outcome measure common to all interventions is
required. Quality Adjusted Life Years (QALYs) are fre-
quently used in economic analyses of healthcare inter-
ventions to provide a common measure of outcome.
QALYs present the impacts of interventions on both
quality and quantity of life in a single, common metric;
thus enabling comparison between interventions in dif-
ferent areas of health care. As such, in addition to pre-
senting the cost-effectiveness in terms of cost per target
achiever, a sensitivity analysis was undertaken to deter-
mine the amount of QALYs that the interventions
would need to generate in order for them to be consid-
ered cost-effective at the usual cost-effectiveness thresh-
olds specified for the UK (£20,000 - £30,000/QALY
[16]). For example, if an intervention led to one
Table 1 resource use and unit costs
Resource use Cost
Minimal
intervention
Maximal
Intervention
Unit cost per
unit or hour
Pedometer 1 1 £ 13.00
Individual physical activity consultation (mins) 5 30 £ 17.50
Walking programme 1 1 £ 1.00
Individual relapse prevention consultation (mins) 5 30 £ 17.50
Physical activity advice leaflet 1 £ 0.16
Follow-up call (mins) 5 8 £ 17.50
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£10,000, then a person achieving the target would have
to generate at least 0.5 QALYs to be considered cost-
effective at £20,000/QALY or ⅓ QALYs to be consid-
ered cost-effective at £30,000/QALY.
Qualitative study
The qualitative evaluation involved four focus group dis-
cussions with participants, and short interviews with six
members of the research team. The focus groups were
convened in order to gain an in-depth understanding of
participants’ views and experiences of the study and a
“valuable insight....into why a successful intervention
works and how it can be optimised”[17]. Typically, a
focus group involves a small number of people (four to
eight) in an informal group discussion focused around a
particular set of issues. The discussion is usually based
on a series of questions (the focus group schedule) and
the researcher generally acts as a moderator for the
group [18].
In this study, separate focus groups were conducted
with the minimal and maximal intervention groups at
the end of the intervention period (i.e. 12 weeks for
maximal and 24 weeks for minimal) and again at
12 month follow-up. The focus group schedule explored
the perceived benefits of increased walking; views on the
pedometer, the physical activity consultations and on-
going support (for maximal intervention); barriers
encountered; future recommendations and reflections
on participation in the study. There was also an oppor-
tunity (at the end of the discussion) for feedback on
topics of importance to participants that were not cov-
ered elsewhere. Participants were recruited via informa-
tion sheets posted to their home addresses. All focus
groups took place in a private room at the study centre
and were facilitated by the lead author (who is an
experienced facilitator). Anonymity and confidentially
were assured. Each group was attended by three to six
participants, lasted for approximately an hour and was
audio-recorded (with permission). The groups consisted
of more women than men, and generally involved more
individuals who had met their targets than those who
h a dn o t( r e f e r r e dt oa s‘high’ and ‘low’ adherers below).
See Table 2 for more details on the participant
breakdown.
The short, semi-structured interviews with members
of the research team (undertaken by the lead author),
covered the aspects of WWW that the researchers
thought had been successful, the challenges of WWW
and how feasible the researchers thought it would be to
implement something similar across the wider commu-
nity. Each of the six key members of the research team
who were interviewed had been involved in implement-
ing and coordinating the intervention.
Focus groups and interviews were transcribed verba-
tim (and anonymised) by the lead author and themati-
cally analysed. The process of thematic analysis involves
“identifying, analysing and reporting patterns (themes)
within data”[19]. Computer software (ATLAS.ti) was
used in order to facilitate the analysis. First, initial codes
were identified, based on careful reading and re-reading
of the data. These codes were then sorted into potential
themes. Direct quotes from the data were grouped
under thematic headings [20], providing a clear illustra-
tion of each theme and also some indication of the fre-
quency with which each theme was addressed. Finally,
the themes were refined through repeated investigation
both of similar and anomalous examples [21]. Quota-
tions were chosen to illustrate particular points and are
identified in the text below by an anonymised code
(indicating focus group (FG) or researcher interview (R),
gender and whether ‘high’ or ‘low’ adherer).
Ethical approval
Appropriate ethical approval was attained from the
University of Strathclyde ethics committee and all pro-
cedures were carried out in accordance with the
Declaration of Helsinki.
Results
Economic evaluation
Table 3 presents the results of the economic analysis,
detailing the costs, outcomes and cost-effectiveness (in
terms of cost per number of participants achieving the
t a r g e to faw e e k l ys t e pi n c r e a s eo f≥15,000 steps)
Table 2 characteristics of focus groups
Gender Average age Adherence
Focus group 1 - Maximal intervention
(12 weeks)
4 women, 1 man 54 (min 45; max 60) 5 High
Focus group 2 - Minimal intervention
(24 weeks)
4 women, 2 men 54 (min 37; max 63) 5 High and 1 Low
Focus group 3 - Maximal intervention
(12 months)
2 women, 1 man 53 (min 38; max 63) 1 High and 2 Low
Focus group 4 - Minimal intervention
(12 months)
3 women 55 (min 51; max 61) 3 High
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intervention.
The results suggest that maintaining “usual behaviour”
(i.e. no intervention), as assessed by the waiting list con-
trol over 12 weeks, leads to four participants achieving a
weekly step increase of ≥15,000 steps at, an assumed,
zero cost. Minimal intervention results in an additional
eight participants achieving the target at an extra cost of
£735. Thus, the cost-effectiveness of the minimal inter-
vention compared to “usual behaviour” is an additional
£92 per additional target achiever (= 735/8). Maximal
intervention results in 13 participants achieving the tar-
get (one more than with the minimal intervention) at a
cost of £1,326 (£591 more than the minimal interven-
tion). Thus, the ICER associated with the maximal inter-
vention, compared to the minimal intervention, is £591
per additional target achiever (£591/1).
These results suggest that either intervention (minimal
or maximal) may be considered cost-effective. The deci-
sion between which of the two to adopt would depend
on the societal value placed on each person achieving
the target. For example, when the value of a person
achieving the target is rated between £92 and £590, then
the minimal intervention w o u l db ec o n s i d e r e dc o s t -
effective. In contrast, if the value placed on a person
achieving the target was £591 or more, then the maxi-
mal intervention would be considered cost-effective.
However, if the value placed on a person achieving the
target was less than £92 neither intervention would be
considered cost-effective.
In the UK, standard thresholds used to determine
cost-effectiveness are based on a societal value for a
QALY (l). These values are typically in the region of
£20,000-£30,000/QALY [16]. A sensitivity analysis was
carried out to assess how many QALYs would need to
result from each person achieving the target for each of
the interventions to be considered cost-effective accord-
ing to these standards (i.e. the weight that would need
to be attached to each target achiever for the ICER of
the intervention to fall below these standard values).
This is determined for each intervention by dividing the
ICER associated with that intervention by the standard
level of cost-effectiveness required (l).
QALY weight required = ICER/λ (2)
Thus, in order for the minimal intervention to be con-
sidered cost-effective at a level of £30,000/QALY,
achieving and maintaining the target of ≥ 15,000 addi-
tional steps per week over 12 months would need to
improve each person’s lifetime QALYs by at least 0.0031
(= 92/30000). If achieving and maintaining the target
over 12 months increased each person’s lifetime QALYs
by more than 0.02 (= 591/30000), then the maximal
intervention would be considered cost-effective against
this standard threshold. This level of increase in QALYs
equates to an increase in survival (in full health), as a
result of the maximal intervention, of 7.3 days over a
lifetime (= 0.02*365), or 1.1 day over a lifetime for the
minimal intervention (= 0.0031*365).
Qualitative evaluation
The data from the four focus groups with participants
(FG) and the six semi-structured interviews with
research staff (R) were combined and analysed together,
and are presented below in terms of three themes repre-
senting: 1) support, 2) monitoring and 3) practical
issues.
Support
Throughout the project, two researchers were primarily
responsible for delivering the intervention and co-
ordinating assessments. Each researcher took responsi-
bility for half of the participants and maintained regular
contact for up to 12-15 months:
We got to know them, they got to know us. We asked
about their family etcetera (R1)
Participants were very positive about the support they
received from these two researchers. So much so, that
as the quote below shows, they were anxious about
what they would do when the support stopped:
If I’m not in the project, I think I’ll lose motivation
completely. I don’t think I’ll be able to continue walk-
ing if I’mn o ti nt h ep r o j e c t(FG 2, male, high
adherer)
Indeed, although the quantitative outcomes showed
that participants maintained increased walking after
Table 3 Cost-effectiveness results
Total cost of
intervention per group
Number achieving weekly
target ≥15,000 steps
Incremental
cost
Incremental
outcome
Incremental cost/target
achiever
“Usual behaviour” £- 4 £- - -
Minimal intervention £ 735 12 £ 735 8 £ 92
Maximal intervention £ 1,326 13 £ 591 1 £591
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group discussions a number of participants spoke of a
lack of motivation, with some also reporting the strate-
gies they had used to overcome this:
Once I’dh a n d e di nt h eb o o ka n dd i d n ’th a v et h e
book anymore, that sort of took away some of the
pressure and my walking dropped off (FG 2, female,
high adherer)
I think writing down what you’ve done is really use-
ful. Since we’ve stopped I’ve been writing it down in
ac h a r tI ’ve drawn myself (FG 3, female, high
adherer)
Monitoring
The majority of respondents felt that the step-count
provided by the pedometer provided useful feedback
which supported and encouraged them:
I think the pedometer was really useful at the begin-
ning because you got tuned into it and checked it
and I realised that my days at home and days at
work were really quite different so I needed to make
a special effort on my days off (FG 4, female, high
adherer)
When initially designing the study, concerns were
expressed by the research staff about the level of partici-
pant burden, particularly in terms of measurement of
health outcomes such as body mass and cholesterol
(which necessitate physical measurements and blood
being taken). In fact, for those who participated in the
study, these health checks were considered an incentive
for their initial and continued involvement in the study:
I wanted to do it because I could get my weight mon-
itored and so on; so I could see if it was actually
having any impact (FG 4, female, high adherer)
I really would have liked to have results every time
we met. That’s the main reason I took part ((blood
pressure etc.)) (FG 4, female, high adherer)
Practical issues
Many of the participants said that walking appealed over
other forms of activity because it was cost-free, could be
undertaken alone without generating feelings of self-con-
sciousness and could fit easily into their daily routine:
I like [walking] because I can do it by myself and I
don’t have to embarrass myself at the gym. I can
afford to do it because it doesn’t cost anything and I
can do it when I’m going to the shops or work (FG 2,
female, high adherer)
In the first pair of focus groups (taking place shortly
following the 12 week intervention), all but one of the
participants had achieved their targets and they had
done this either by making time for walks during the
d a y( " It r yt ot a k eaw a l ke v e r yd a y ” (FG 1, male,
high adherer)), or by incorporating it into their daily
activities:
I haven’ts e to u tt ow a l ke v e r y d a y ;i n s t e a dI ’ve tried
to incorporate it into what I usually do. So rather
than taking the bus to ((Place)), I’ll now walk and it
means taking much more time to actually get there
(FG 1, female, high adherer)
Participants also mentioned the physical, social and
emotional benefits of increasing walking:
Yes, when I drop off my daughter and go for a walk I
feel invigorated. It makes you wonder why you don’t
do it more (FG 1, female, high adherer)
On my way home I park up at the Botanic Gardens
and go for a walk. And I’ve seen things I didn’t know
about. I didn’t know there was a disused railway
track in the Botanic Gardens! It’s a great way of get-
ting out there and seeing things that I hadn’td o n e
before and meeting the gardeners you know, when
you stop for a breath (FG 1, female, high adherer)
Respondents mentioned a number of barriers to
increased walking, such as bad weather ("I hit a rough
patch when we had that wet period”, FG 1, male, high
adherer) and boredom, especially amongst those who
had tried to initiate a walk during the day, outside their
usual daily activities. In addition, those who’dt r i e dt o
incorporate walking into ordinary daily activities, like
walking to the shops or to work, mentioned barriers
such as lack of time and practical issues such as carrying
shopping, laptops etc.:
I found it quite hard walking to work at times. When
I have meetings or whatever and I have a laptop to
carry, I’m wearing a suit and heels, I just can’td oi t .
So I jump in the car. I’m still trying to take the stairs
at work, but more often than not I drive to work
now. I mean, it sounds very vain, but I straighten my
hair every morning and if it’s bad weather, or even a
bit damp and I walk, my hair is a frizzy mess by the
time I get to work (FG 3, female, low adherer)
Discussion
The results from the economic analysis suggest that
pedometer based walking interventions, as trialled in the
WWW study, may be considered cost-effective depend-
ing on the monetary value placed on, or the QALY
weight attached to, a person achieving the target. The
sensitivity analysis suggests that if the minimal
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full health it would be considered cost-effective by
established standards in the UK. The 12 month effec-
tiveness data indicates that while walking levels fell from
those seen immediately post-intervention, increased
walking over baseline values can be maintained over a
longer time period. If this continued to be the case then
impacts on physical health, such as blood pressure,
inflammatory markers or weight which were not
observed in this group over the short term [8,23], may
start to materialise either due to improvements or due
to reductions in the extent of decline in these levels
over time.
The results from the qualitative evaluation provide
information for policymakers about the process by
which the study results were achieved and give insight
into the barriers and facilitators that need to be
acknowledged or addressed before implementing the
intervention in the wider community. Some of the issues
(for example, the impact of the relationship between
researchers and participants on the results) will be spe-
cific to the study, but others (for example, the trade-off
between walking and commuting) may apply to other
walking or physical activity projects more generally.
These issues need to be considered in order to deter-
mine whether the results from the study are likely to be
replicated in the wider community.
When asked whether they thought it would be feasible
to implement something similar in the community, one
researcher said:
Super feasible, I don’t see any problem at all. Ped-
ometers cost buttons; I think it would be really easy
to run, especially without having people to come in
for assessments (R3)
Although the interventions are straightforward and the
underlying concept is simple (a pedometer based walk-
ing programme and relatively brief advice), a major part
of the intervention’s success may be due to the support
and expertise provided by the researchers working on
the WWW study. As shown in the qualitative analysis
above, the sustained contact between participant and
researcher, necessary for maintaining follow-up in the
study setting, may itself have provided motivation to
participants and was certainly appreciated by them. In
addition, the qualitative analysis showed that the health
checks were also perceived to be a motivating factor.
It is not clear how much of the effectiveness of the
interventions should be attributed to these contacts and
assessments, or whether the removal of such contacts
and assessments would have a critical impact on the
effectiveness of the interventions. In this case, while the
intervention would be “really easy to run... without
having people to come in for assessments” (R3), it may
not provide the same outcomes. Further research is
needed to explore delivery of on-going individual level
support, as provided by the two researchers in this
study, on a wider scale. In addition, it should be noted
that the economic evaluation of WWW did not take full
account of this level of input from the researchers and
did not include the costs of assessment (which were
seen to be driven by the study protocol). Thus, in order
to replicate this level of cost-effectiveness in the com-
munity, the implementation would require a similar
level of effectiveness from the interventions without the
contact and assessments (i.e. there would need to be no
impact of the contact and assessments on the
effectiveness).
In the post intervention focus groups, some partici-
pants suggested ways in which this support could be
provided differently, in particular highlighting walking
groups. The Scottish Physical Activity Research Colla-
boration (SPARColl, http://www.sparcoll.org.uk) is cur-
rently evaluating the feasibility of wider implementation
of the WWW interventions with support provided via
community and workplace health walks [24]. This work
will include process and outcome evaluation methods
which may help to ascertain the level of support
required by participants and walk leaders, to successfully
implement the intervention in the community.
Limitations with this analysis
In the initial analysis plan, as described in Fitzsimons
et al. (2008) [10], the economic evaluation was due to
include the differences in costs resulting from changes
in NHS resource use between the interventions and the
waiting list control ("usual behaviour”). Unfortunately, it
was not possible to estimate the impact of the interven-
tion on healthcare resource use (for example, hospitali-
sations and GP consultations) as this data was only
collected for the maximal and minimal groups post
intervention. As such, the slight reduction in resource
use for the maximal intervention group identified at
1 2m o n t h s ,c o m p a r e dt ob o t ht h e“usual behaviour”
control and minimal intervention groups, may simply
reflect differences present at baseline, rather than
changes in the use of these resources that related to the
intervention. The exclusion of these costs limits the ana-
lysis to focus only on the short term costs of providing
the intervention and potentially underestimates the cost-
effectiveness of maximal intervention compared with
both minimal intervention and “usual behaviour”.
Despite the availability of EQ-5D data, from which
estimates of within study quality adjusted life years
(QALYs) could be calculated, the primary economic
analysis reported here involved the number of partici-
pants achieving the target of ≥ 15,000 additional steps
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the QALYs generated within the trial period (i.e.
12 months), would require the assumption that there
was no long term impact of the interventions on either
length or quality of life. Given that increased physical
activity is associated with reductions in obesity, cardio-
vascular disease and cancer [1] this seems an unnecessa-
rily restrictive assumption. Alternatively, an analysis
based on lifetime QALYs gained would require the
determination of the impacts of the interventions on
both length and quality of life. This, in turn, would
involve identifying and modelling the complex long
term impacts of the interventions on various aspects of
health and quality of life, for which there is currently
very little data. The reliance on a measure of outcome
specific to walking/physical activity interventions limits
the ability of the policymaker to compare the cost-
effectiveness of the interventions to that of interventions
in other areas of health. The sensitivity analysis goes
someway to address this by providing an indication of
the quality of life impact required for the interventions
to be considered cost-effective by the standards usually
employed in the UK [16].
Conclusion
The results of the economic and qualitative analyses of
the WWW study suggest that pedometer based walking
interventions may be considered cost-effective and suita-
ble for implementation within the wider community.
However, several research gaps remain, including the
importance and impact of the researcher/participant
relationship, the impact of assessment on motivation
and effectiveness, and the longer term impact on physi-
cal health, resource utilisation and quality of life. Some
of these gaps should be addressed by the implementa-
tion study currently underway in Glasgow [24], while
others will require studies with longer follow-up, such
as those recently commissioned by the National Institute
for Health Research (NIHR) Health Technology Assess-
ment (HTA) programme.
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